Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xilio Therapeutics (XLO) Equity Ratio (2024 - 2025)

Historic Equity Ratio for Xilio Therapeutics (XLO) over the last 2 years, with Q3 2025 value amounting to 0.06.

  • Xilio Therapeutics' Equity Ratio fell 12155.26% to 0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06, marking a year-over-year decrease of 12155.26%. This contributed to the annual value of 0.25 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Xilio Therapeutics' Equity Ratio is 0.06, which was down 12155.26% from 0.05 recorded in Q2 2025.
  • Xilio Therapeutics' Equity Ratio's 5-year high stood at 0.37 during Q2 2024, with a 5-year trough of 0.06 in Q3 2025.